115 related articles for article (PubMed ID: 9426201)
1. "Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection.
Bardelli A; Pugliese L; Comoglio PM
Biochim Biophys Acta; 1997 Dec; 1333(3):M41-51. PubMed ID: 9426201
[No Abstract] [Full Text] [Related]
2. Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.
Yerushalmi GM; Leibowitz-Amit R; Shaharabany M; Tsarfaty I
Neoplasia; 2002; 4(6):510-22. PubMed ID: 12407445
[TBL] [Abstract][Full Text] [Related]
3. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.
van der Voort R; Taher TE; Derksen PW; Spaargaren M; van der Neut R; Pals ST
Adv Cancer Res; 2000; 79():39-90. PubMed ID: 10818677
[TBL] [Abstract][Full Text] [Related]
4. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
5. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
To CT; Tsao MS
Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803
[TBL] [Abstract][Full Text] [Related]
6. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
7. Control of invasive growth by the HGF receptor family.
Maggiora P; Gambarotta G; Olivero M; Giordano S; Di Renzo MF; Comoglio PM
J Cell Physiol; 1997 Nov; 173(2):183-6. PubMed ID: 9365519
[No Abstract] [Full Text] [Related]
8. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
[TBL] [Abstract][Full Text] [Related]
9. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
[TBL] [Abstract][Full Text] [Related]
10. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met.
Weidner KM; Hartmann G; Sachs M; Birchmeier W
Am J Respir Cell Mol Biol; 1993 Mar; 8(3):229-37. PubMed ID: 8383506
[TBL] [Abstract][Full Text] [Related]
11. [HGF/c-Met and metastasis of hepatocellular carcinoma].
Xie B; Dong JH
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):396-8. PubMed ID: 15918987
[No Abstract] [Full Text] [Related]
12. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
14. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.
Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD
Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069
[TBL] [Abstract][Full Text] [Related]
16. Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.
Tachibana K; Minami Y; Shiba-Ishii A; Kano J; Nakazato Y; Sato Y; Goya T; Noguchi M
Lung Cancer; 2012 Feb; 75(2):181-8. PubMed ID: 21872356
[TBL] [Abstract][Full Text] [Related]
17. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Bigelow RL; Cardelli JA
Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
[TBL] [Abstract][Full Text] [Related]
18. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM
Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872
[TBL] [Abstract][Full Text] [Related]
19. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.
Weidner KM; Sachs M; Birchmeier W
J Cell Biol; 1993 Apr; 121(1):145-54. PubMed ID: 8384622
[TBL] [Abstract][Full Text] [Related]
20. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
